Research has shown that GLP-1 medications are associated with modest weight loss
Ozempic is a single action medication that targets one receptor, Mounjaro is dual-action and targets two receptors, making it slightly more effective
"Practicing healthy habits is not about perfection," said Tara Schmidt, Lead Dietitian for The Mayo Clinic Diet, Host of the Mayo Clinic On Nutrition podcast and co-author of The Mayo Clinic Diet: Weight-Loss Medications Edition
They have more than 81,500 patients who have lost over 2.1 million pounds with their physician-supervised, personalized weight loss programs, always focused on your confidence, health, and lasting change
Inadequate dose escalation is the most frequent cause of apparent treatment failure
It requires medical expertise